Cardiovascular complications of immune checkpoint inhibitors
Cardiovascular toxicity of cancer therapies remains an urgent problem today. The creation of highly effect antitumor drugs also means the appearance of new adverse effects. Immune checkpoint inhibitors (ICI) is a new class of antitumor drugs that is different from traditional chemotherapeutic and ta...
Gorde:
| Egile Nagusiak: | , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Russo |
| Argitaratua: |
Izdatelstvo OKI
2020-04-01
|
| Saila: | Качественная клиническая практика |
| Gaiak: | |
| Sarrera elektronikoa: | https://www.clinvest.ru/jour/article/view/477 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|